dc.contributor | IDIAP Jordi Gol |
dc.contributor.author | Morros, Rosa |
dc.contributor.author | Giner-Soriano, Maria |
dc.contributor.author | Gomez-Lumbreras, Ainhoa |
dc.contributor.author | Ouchi, Dan |
dc.contributor.author | Vedia Urgell, Cristina |
dc.date.accessioned | 2022-06-10T08:50:08Z |
dc.date.available | 2022-06-10T08:50:08Z |
dc.date.issued | 2022-06-08 |
dc.identifier.citation | Giner‑Soriano M, Gomez‑Lumbreras A, Vedia C, Ouchi D, Morros R. Risk of thrombotic events and other complications in anticoagulant users infected with SARS-CoV-2: an observational cohort study in primary health care in SIDIAP (Catalonia, Spain). BMC Prim Care. 2022 Jun 8;23(1):147. |
dc.identifier.issn | 2731-4553 |
dc.identifier.uri | https://hdl.handle.net/11351/7659 |
dc.description | COVID-19; Anticoagulantes orales; Eventos trombóticos; Atención primaria |
dc.language.iso | eng |
dc.publisher | Springer Nature |
dc.relation.ispartofseries | BMC Primary Care;23(1) |
dc.rights | Attribution 4.0 International |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Farmacoepidemiologia |
dc.subject | Anticoagulants (Medicina) - Efectes secundaris |
dc.subject | COVID-19 (Malaltia) |
dc.subject.mesh | Pharmacoepidemiology |
dc.subject.mesh | Anticoagulants |
dc.subject.mesh | Coronavirus Infections |
dc.title | Risk of thrombotic events and other complications in anticoagulant users infected with SARS‑CoV‑2: an observational cohort study in primary health care in SIDIAP (Catalonia, Spain) |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1186/s12875-022-01752-5 |
dc.subject.decs | farmacoepidemiología |
dc.subject.decs | anticoagulantes |
dc.subject.decs | infecciones por Coronavirus |
dc.relation.publishversion | https://doi.org/10.1186/s12875-022-01752-5 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.authoraffiliation | [Giner Soriano M, Gomez Lumbreras A, Ouchi D] Fundació Institut Universitari per a la Recerca a L’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain. Universitat Autònoma de Barcelona (UAB), Bellaterra, Spain. [Vedia C] Unitat de Farmàcia, Servei d’Atenció Primària Barcelonès Nord i Maresme, Institut Català de la Salut (ICS), Badalona, Spain. Departament de Farmacologia, Terapèutica i Toxicologia, Universitat Autònoma de Barcelona (UAB), Bellaterra, Spain. [Morros R] Fundació Institut Universitari per a la Recerca a L’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain. Departament de Farmacologia, Terapèutica i Toxicologia, Universitat Autònoma de Barcelona (UAB), Bellaterra, Spain. Institut Català de la Salut (ICS), Barcelona, Spain. Plataforma SCReN, UICEC IDIAP Jordi Gol, Barcelona, Spain |
dc.identifier.pmid | 35676639 |
dc.relation.projectid | EUPAS Register: EUPAS37205 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |